INSITE VISION INC 4
4 · INSITE VISION INC · Filed Nov 4, 2015
Insider Transaction Report
Form 4
Hosseini Kamran
VP, Clinical Affairs & CMO
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2015-11-02−40,000→ 0 totalExercise: $0.60From: 2009-03-24Exp: 2018-03-24→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02$0.35/sh−300,000$105,000→ 0 totalExercise: $0.20From: 2010-02-17Exp: 2019-02-17→ Common Stock (300,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02−250,000→ 0 totalExercise: $0.50From: 2013-01-27Exp: 2022-01-27→ Common Stock (250,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02$0.35/sh−325,000$113,750→ 0 totalExercise: $0.29From: 2015-01-07Exp: 2024-01-07→ Common Stock (325,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02−300,000→ 0 totalExercise: $0.42From: 2011-04-01Exp: 2020-04-01→ Common Stock (300,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02$0.35/sh−325,000$113,750→ 0 totalExercise: $0.32From: 2014-01-24Exp: 2023-01-24→ Common Stock (325,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02$0.35/sh−325,000$113,750→ 0 totalExercise: $0.21From: 2016-01-28Exp: 2025-01-28→ Common Stock (325,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-11-02−250,000→ 0 totalExercise: $0.36From: 2012-01-21Exp: 2021-01-21→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]The option is scheduled to vest as to 25% of the shares covered by the option on the first anniversary of the grant date and as to the remaining 75% of the shares on a daily basis over the three-year period thereafter.
- [F2]In accordance with the terms of the Agreement and Plan of Merger, dated September 15, 2015, as amended and restated, by and among Thea Acquisition Corp ("Purchaser"), Ranbaxy, Inc. and InSite Vision Incorporated ("Issuer") pursuant to which Purchaser was merged with and into Issuer (the "Merger"), this stock option was cancelled at the effective time of the Merger without consideration because the exercise price of the stock option equaled or exceeded $0.35 per share.
- [F3]This option was cancelled in connection with the Merger in exchange for a cash payment per share equal to the difference between $0.35 and the exercise price of the option.